Inhibitory effect of thromboxane A2 synthetase inhibitor, DP-1904, on antigen-induced contraction of human lung parenchyma

Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
C FukushimaK Hara

Abstract

Several mediators are released from mast cells during allergic reactions. These substances cause contraction of airway smooth muscles, increase the permeability of blood vessels, and enhance mucous secretion. Among these mediators, thromboxane A2 (TXA2) has a particularly strong bronchoconstrictive effect. We examined antigen-induced contraction of excised human lungs and the suppressive effects of TXA2 synthetase inhibitor on TXA2 release. Human lung parenchymal strips were subjected to passive sensitization with sera of 5+ RAST titer to the mite. They were suspended in magnus baths, to which buffer and 10(-4) to 10(-8) M of DP-1904, an inhibitor of TXA2 synthetase, were added. Following the measurement of TXB2 and leukotriene (LT) concentrations in each bath, parenchymal contraction was induced by the addition of a mite antigen. The concentration of TXB2 and LT was measured after contraction. Antigen-induced release of TXB2 was significantly suppressed by DP-1904 in a concentration-dependent manner. DP-1904 did not inhibit parenchymal contraction and the release of LT. Antigen-induced parenchymal contraction was not suppressed by inhibition of TXA2 release, suggesting that DP-1904 may not be effective in asthma.

References

Jan 1, 1992·International Archives of Allergy and Immunology·A ArimuraM Harada
Jun 1, 1992·The American Review of Respiratory Disease·G L JonesP M O'Byrne
Jan 1, 1991·Annals of the New York Academy of Sciences·M TakamiW Tsukada
Jan 1, 1991·The American Review of Respiratory Disease·I K TaylorR W Fuller
Jun 1, 1990·The American Review of Respiratory Disease·K SladekJ R Sheller
Oct 1, 1989·The American Review of Respiratory Disease·M D LupinettiG A Fitzgerald
Feb 1, 1988·The American Review of Respiratory Disease·S R KleebergerE W Spannhake
Jan 1, 1988·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·I IwamotoS Yoshida
Aug 1, 1983·British Journal of Pharmacology·G A HiggsK Seager
Apr 1, 1993·The American Review of Respiratory Disease·B S FriedmanP Sterk
Jun 1, 1993·The American Review of Respiratory Disease·H K MakkerS T Holgate
Jun 1, 1993·The American Review of Respiratory Disease·N ImpensA G Dupont

❮ Previous
Next ❯

Citations

Mar 11, 1999·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·C FukushimaS Kohno
Apr 9, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·C FukushimaS Asai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.